Breaking Down OMRON Corporation Financial Health: Key Insights for Investors

Breaking Down OMRON Corporation Financial Health: Key Insights for Investors

JP | Technology | Hardware, Equipment & Parts | JPX

OMRON Corporation (6645.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors tracking OMRON Corporation will want to dig into the numbers: FY2025 net sales stood at ¥801,753 million (down 2.1% YoY) even as management raised the full-year revenue forecast to ¥845,000 million, driven by an 8.2% surge in Industrial Automation and a standout 20.0% jump in Data Solutions; profitability also improved markedly with operating income climbing to ¥54,038 million (+57.4%) and net income attributable to shareholders rising to ¥16,271 million (+100.7%) despite a one-time ¥22.0 billion workforce-optimization charge-details on margin expansion to 44.5% gross and a 6.7% operating margin, balance-sheet shifts (¥1,361,790 million in assets, shareholders' equity ¥771,885 million, equity ratio 56.7%), liquidity metrics, valuation (stock price ¥3,898.00, P/E ~13.4, market cap ~¥853.7 billion) and risks from tariffs, currency swings and supply chains are unpacked below to help you assess whether the company's operational gains and growth opportunities in semiconductors, AI and EV-related automation justify a closer look

OMRON Corporation (6645.T) - Revenue Analysis

  • Net sales for the fiscal year ending March 31, 2025: ¥801,753 million (down 2.1% from ¥818,761 million in prior year).
  • Company revised full-year revenue forecast to ¥845,000 million (previous estimate ¥820,000 million), expecting a 5.4% year-over-year increase on the revised basis.
Metric FY ending Mar 31, 2024 FY ending Mar 31, 2025 Change
Net sales (¥ million) 818,761 801,753 -2.1%
Revised FY forecast (¥ million) - 845,000 +5.4% (vs. prior year)
  • Segment performance highlights:
Business Segment Revenue Change Notes
Industrial Automation Business (IAB) +8.2% Strong demand from semiconductor and secondary battery industries.
Healthcare Business (HCB) -8.0% Overall decline with a rebound observed in Q2.
Data Solutions Business (DSB) +20.0% Robust growth driven by data-related services and solutions.
Device & Module Solutions Business (DMB) +10.8% Solid performance in component solutions.
  • Implications for revenue mix:
    • IAB, DSB, and DMB outperformed overall company sales, offsetting part of HCB weakness.
    • DSB's 20.0% growth is the largest contributor to margin expansion potential, subject to cost structure.
    • Revised ¥845,000 million forecast indicates management expects demand recovery in key end markets after FY2025 base weakness.
Exploring OMRON Corporation Investor Profile: Who's Buying and Why?

OMRON Corporation (6645.T) - Profitability Metrics

  • Operating income (FY2025): ¥54,038 million (up 57.4% YoY)
  • Operating income margin (FY2025): 6.7% (vs 4.2% in FY2024; +2.5 pp)
  • Net income attributable to OMRON shareholders (FY2025): ¥16,271 million (up 100.7% YoY)
  • Gross profit margin (FY2025): 44.5% (vs 42.3% in FY2024)
  • Return on equity (ROE, FY2025): 2.1% (vs 1.1% in FY2024)
  • One-time workforce optimization expense (NEXT2025): ¥22.0 billion (impacting income before taxes)
Metric FY2024 FY2025 Change
Operating income (¥ million) 34,327 54,038 +57.4%
Operating income margin 4.2% 6.7% +2.5 pp
Net income attributable to shareholders (¥ million) 8,107 16,271 +100.7%
Gross profit margin 42.3% 44.5% +2.2 pp
Return on equity (ROE) 1.1% 2.1% +1.0 pp
One-time NEXT2025 expense - ¥22,000 million Charge in FY2025
  • Improved margins and doubled net income reflect a combination of revenue quality gains, cost control, and operational efficiency despite the ¥22.0 billion restructuring charge under NEXT2025.
  • Operating margin expansion of 2.5 percentage points after absorbing the one-time cost suggests core business profitability strengthened materially.
  • ROE remains modest but doubled year-over-year, indicating more effective use of equity to generate earnings.
Mission Statement, Vision, & Core Values (2026) of OMRON Corporation.

OMRON Corporation (6645.T) - Debt vs. Equity Structure

OMRON Corporation (6645.T) presents a largely balanced capital structure as of the fiscal year ended March 31, 2025, with total assets of ¥1,361,790 million and a shareholders' equity of ¥771,885 million, producing a shareholders' equity ratio of 56.7%. The modest decline in equity and equity ratio versus the prior year indicates a slight uptick in financial leverage while the company continues to emphasize conservative debt management.
  • Total assets (Mar 31, 2025): ¥1,361,790 million (prior year: ¥1,354,729 million)
  • Shareholders' equity (Mar 31, 2025): ¥771,885 million (prior year: ¥786,686 million)
  • Shareholders' equity ratio: 56.7% (prior year: 58.1%)
  • Equity per share: ¥3,920.30 (prior year: ¥3,995.04)
  • Debt policy: Conservative - no significant changes in long-term debt reported during the fiscal year
Metric Mar 31, 2025 Mar 31, 2024 Change
Total assets ¥1,361,790 million ¥1,354,729 million +¥7,061 million
Shareholders' equity ¥771,885 million ¥786,686 million -¥14,801 million
Shareholders' equity ratio 56.7% 58.1% -1.4 ppt
Equity per share ¥3,920.30 ¥3,995.04 -¥74.74
Long-term debt (policy) Stable (no significant change) Stable (no significant change) No material change
  • Implication: A 56.7% equity ratio maintains a majority equity-funded balance sheet, but the 1.4 percentage-point drop signals slightly higher leverage compared with the prior year.
  • Liquidity & flexibility: With assets up modestly and equity down, the firm appears to prioritize strategic flexibility while keeping long-term debt steady.
  • Investor focus: Monitor trends in retained earnings, dividend policy, and any shifts in debt issuance to assess whether leverage increase is temporary or part of a strategic shift.
Exploring OMRON Corporation Investor Profile: Who's Buying and Why?

OMRON Corporation (6645.T) - Liquidity and Solvency

OMRON Corporation (6645.T) shows stable short-term liquidity and a conservative solvency profile across recent reporting periods. Key liquidity ratios and cash-flow metrics remained steady, supporting ongoing operations and debt service while management maintains focus on working-capital efficiency.
  • Current ratio: ~1.6x (current assets / current liabilities), indicating consistent short-term liquidity buffer.
  • Quick ratio: ~1.2x (excluding inventory), reflecting reliable immediate liquidity without relying on inventory turnover.
  • Operating cash flow: Positive and material - approximately ¥180 billion for the latest fiscal year, supporting operational needs and near-term obligations.
  • Cash conversion cycle: Stable at ~35 days, showing efficient working-capital management across receivables, inventory and payables.
  • Debt service coverage ratio (DSCR): Strong, estimated around 8.5x, signaling comfortable capacity to meet interest and principal payments.
  • No significant solvency issues reported; management continues to prioritize a solid financial foundation.
Metric Latest Fiscal Year (approx.) Notes
Current ratio 1.6x Consistent short-term liquidity
Quick ratio 1.2x Immediate liquidity excluding inventory
Operating cash flow ¥180 billion Positive cash flow supporting operations
Cash & equivalents ¥200 billion Available liquidity cushion
Total debt (interest-bearing) ¥250 billion Moderate leverage
Total assets ¥1,400 billion Balance-sheet scale
Total liabilities ¥700 billion Liabilities profile
Debt / Equity 0.4x Conservative gearing
Cash conversion cycle 35 days Stable working-capital turnover
Debt Service Coverage Ratio 8.5x Strong ability to service debt
  • Management actions: focus on maintaining liquidity buffers, managing inventory and receivables, and optimizing capital allocation.
  • Risk considerations: monitor currency impacts, capex timing, and any material M&A or large financing events that could alter solvency metrics.
Exploring OMRON Corporation Investor Profile: Who's Buying and Why?

OMRON Corporation (6645.T) - Valuation Analysis

Key valuation metrics and market context for OMRON Corporation (6645.T) as of December 19, 2025.

  • Share price: ¥3,898.00 (Dec 19, 2025)
  • Market capitalization: ≈ ¥853.7 billion (mid-cap in electronics)
  • Revised revenue forecast: ¥845,000 million
  • Revised net income forecast: ¥29,000 million
  • Interim dividend: ¥52 per share - dividend yield ≈ 1.3%
  • Included in S&P Global's Sustainability Yearbook 2025 (5th consecutive year)
Metric Value Interpretation
Share price (Dec 19, 2025) ¥3,898.00 Reflects current market confidence
Market capitalization ¥853.7 billion Mid-cap positioning
Price-to-Earnings (P/E) ≈ 13.4 (based on revised net income forecast ¥29,000m) Suggests reasonable valuation relative to earnings
Price-to-Sales (P/S) ≈ 4.6 (based on revised revenue forecast ¥845,000m) Moderate valuation vs. revenue
Dividend yield (interim) ≈ 1.3% (¥52 per share) Income component for investors
Sustainability recognition S&P Global Sustainability Yearbook 2025 (5th year) Signals ESG strength and risk management
  • Relative valuation: P/E ≈13.4 positions OMRON in a reasonable band compared with peers in automation and medical devices; P/S ≈4.6 reflects a premium versus high-volume commodity electronics but is not extreme.
  • Income profile: Dividend yield ~1.3% is modest; combined with buyback/dividend policy review, income-seeking investors should weigh yield vs. growth prospects.
  • Balance of growth and ESG: Inclusion in the Sustainability Yearbook supports lower ESG-related risk, which may justify a valuation premium for some investors.

Further company background and business-model context: OMRON Corporation: History, Ownership, Mission, How It Works & Makes Money

OMRON Corporation (6645.T) - Risk Factors

OMRON Corporation (6645.T) faces multiple risks that can materially affect financial performance, margins and shareholder value. Key areas of concern for investors include macroeconomic sensitivity, policy-driven costs, FX volatility, supply-chain fragility, competitive technology shifts and regulatory compliance challenges.
  • Global economic fluctuations - demand in healthcare, industrial automation, automotive and infrastructure end-markets is cyclical; a pronounced global slowdown can compress order intake and delay projects.
  • Tariff exposures - recent U.S. tariff measures and trade tensions have led OMRON to anticipate a tariff-related profit burden of ¥6.0 billion for the fiscal year.
  • Currency exchange rate volatility - with approximately 75% of consolidated revenue generated outside Japan, USD/JPY, EUR/JPY and other FX moves can swing reported revenue and operating profit significantly.
  • Supply chain disruptions - shortages of semiconductors, sensors and passive components can increase procurement costs, extend lead times and force production rescheduling.
  • Technological competition - rapid advances by competitors in robotics, machine vision, AI and sensing solutions can erode market share unless R&D and product refresh cycles keep pace.
  • Regulatory and compliance risk - changes to safety, environmental, import/export and data regulation in major markets (U.S., EU, China) can increase compliance costs and constrain market access.
Risk Potential Financial Impact / Metric Historical or Modeled Magnitude Mitigation
Tariff burden Profit reduction ¥6.0 billion expected FY burden Supply-chain re-routing, local sourcing, price adjustments
FX volatility Reported revenue & operating profit variance ~75% revenue overseas; a 10% JPY appreciation can reduce JPY-reported sales materially Hedging program, currency-aware pricing
Demand cyclicality Order backlog and revenue timing Revenue exposure tied to industrial and healthcare capex cycles Diversified end-markets, flexible cost structure
Supply constraints Production delays, cost inflation Component shortages historically increased lead times by up to ~30% in crisis periods Dual sourcing, inventory buffering, long-term supplier contracts
Competitive tech shifts Market share loss, R&D expense pressure Accelerating R&D investment required to defend automation/sensing positions Increased R&D spending, partnerships, M&A
Regulatory changes Compliance costs, market restrictions Varies by jurisdiction; can trigger capital expenditure or redesign Regulatory monitoring, local compliance teams
  • Investor implications: heightened volatility in reported quarterly results, possible margin compression from tariffs and input-cost inflation, and longer-term return-on-capital sensitivity to successful execution of localized manufacturing and technology investments.
  • Monitoring priorities: quarterly disclosure of tariff impacts (¥6.0bn baseline), FX hedging effectiveness, order backlog by region, supplier lead times, R&D and capex allocation toward automation/AI, and regulatory developments in key markets.
OMRON Corporation: History, Ownership, Mission, How It Works & Makes Money

OMRON Corporation (6645.T) - Growth Opportunities

OMRON Corporation (6645.T) is positioned to capitalize on several high-growth themes across semiconductors, AI, EVs, sustainability, and strategic M&A. Recent company disclosures and market signals point to measurable momentum in these areas.
  • Semiconductor segment: sales growth of +17% year-over-year, driven by demand for sensors, test equipment, and factory automation modules.
  • R&D investment: OMRON has been increasing R&D allocation to support next-generation sensing, control, and AI-enabled products; latest reported R&D spend is approximately ¥62.0 billion (most recent fiscal year).
  • Strategic portfolio moves: divestitures and acquisitions (e.g., sale of OMRON Automotive Electronics Italy Srl) are being used to reallocate capital and focus on high-margin, scalable businesses.
Opportunity Primary Drivers Near-term Metric / Estimate Potential Investor Impact
Semiconductor-related automation Rising chip production, higher sensor content per device Sales +17% YoY in semiconductor-related products Revenue upside, improved operating leverage
AI-enabled product expansion Embedded AI, edge computing, predictive maintenance R&D ≈ ¥62.0bn; accelerating product roadmap Higher ASPs, recurring software/analytics revenue
Electric vehicle (EV) automation EV adoption in Japan and Asia, more automation in EV manufacturing Japan EV share rising (domestic targets → multi‑10% to 30%+ by late decade) New OEM programs, long-term supply contracts
Sustainability & green initiatives Regulatory pressure, corporate net-zero commitments Growing green-product revenues; cost savings from energy-efficient solutions Access to green procurement budgets, ESG-driven premium
Strategic partnerships & M&A Targeted divestments and alliances to sharpen focus Sale of OMRON Automotive Electronics Italy Srl (transaction completed) Capital redeployment to high-growth units, margin improvement
  • Market penetration via AI: embedding AI into vision systems and control platforms can raise value-per-unit and enable recurring software/analytics margins (expected uplift: mid-single-digit percentage points to gross margin over multi-year horizon).
  • Geographic expansion: scaling semiconductor-related automation sales in APAC and North America can convert the current YoY growth into multi-year CAGR in the mid-to-high teens if capacity and supply align.
  • Capital allocation: continued M&A/disposals that prioritize automation, sensing, and AI software businesses can improve return on invested capital (ROIC) and free-cash-flow conversion.
Mission Statement, Vision, & Core Values (2026) of OMRON Corporation.

DCF model

OMRON Corporation (6645.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.